This Week's Biggest Criminal Cases, Explained as They Unfold

The Gilgo Beach Case Ends With a Confession, Not a Verdict

After nearly three decades of unsolved murders and more than two years of courtroom proceedings, the Gilgo Beach serial killings case reached its conclusion not through a jury's deliberation but through a guilty plea delivered in a Suffolk County courtroom in Riverhead, New York. Rex Heuermann, a 62-year-old former New York architect, pleaded guilty on April 8 to murdering seven women and admitted responsibility for an eighth, closing one of the longest-running serial murder investigations in modern American history.

Heuermann confessed to killing eight women: Maureen Brainard-Barnes, Melissa Barthelemy, Megan Waterman, Amber Costello, Jessica Taylor, Valerie Mack, Sandra Costilla, and Karen Vergata. The killing spree spanned 1993 to 2011, and the case had gone cold for years before a traffic stop in December 2010 led investigators to the stretch of beachfront where the first four bodies were discovered.

The forensic detail that finally anchored Heuermann to one of his victims underscores just how granular modern evidence can be. Prosecutors revealed that Heuermann was linked to victim Megan Waterman by the distinct pattern on a Bounty paper towel found at the scene, a piece of physical evidence so specific it became central to the district attorney's account of the case. Heuermann was arrested in July 2023 and charged with the killings of three of the "Gilgo Four" victims; prosecutors later charged him with four more murders in incidents dating as far back as 1993.

He is expected to be sentenced to life in prison without parole, three consecutive life sentences, followed by four sentences of 25 years to life. Heuermann is scheduled to be sentenced on June 17.

Why It Matters: The guilty plea spares the victims' families a prolonged trial but raises a harder question: are more victims still unidentified? Investigators have long suspected the total number of Gilgo Beach victims exceeds those charged. The next date to watch is the June 17 sentencing hearing, where prosecutors are expected to present the full scope of Heuermann's conduct and families will deliver victim impact statements.

The "Ketamine Queen" Sentenced in Matthew Perry's Death

Jasveen Sangha, the drug dealer dubbed the "Ketamine Queen," was sentenced to 15 years in federal prison on April 8, 2026, for her role in supplying the ketamine that killed Friends star Matthew Perry. The sentencing was delivered by U.S. District Judge Sherilyn Peace Garnett in Los Angeles. Perry, 54, died in October 2023 from the acute effects of ketamine.

Sangha was the third defendant sentenced of the five people who pleaded guilty in connection with the 2023 overdose of the actor. In September 2025, Sangha entered a guilty plea on five federal charges: one count of maintaining a drug-involved premises, one count of distribution resulting in death, and three counts of ketamine distribution. She had remained in custody since August 2024.

The picture painted in court was not of a low-level street dealer but of a deliberate, high-volume operation. Prosecutors described Sangha as running a "high volume drug trafficking business out of her North Hollywood residence," marketing herself as a dealer who sold exclusively to Hollywood's elite. Judge Garnett noted at sentencing that Sangha continued to operate her drug distribution network despite knowing about earlier overdose deaths.

Sangha admitted to working with another dealer to provide Perry with dozens of vials of ketamine in the weeks before his fatal overdose.

Why It Matters: The Perry case has forced a broader reckoning with prescription drug diversion and the intersection of celebrity culture and illicit pharmaceutical networks. With three of five defendants now sentenced, the remaining proceedings will determine whether the full web of suppliers faces proportionate accountability. The key unresolved question is what cooperation deals the other defendants offered prosecutors, and whether any investigation into the supply chain above Sangha continues.

Luigi Mangione: Two Trials, Two Delays, and a Double Jeopardy Argument

Luigi Mangione, 27, is accused of fatally shooting UnitedHealthcare CEO Brian Thompson in Midtown Manhattan in December 2024. He faces parallel proceedings in both federal and state courts in New York, and this week those dual timelines were thrown into further flux.

Judge Margaret Garnett declined to move the federal trial to next year, instead modifying the dates modestly: she pushed the start of jury selection to October 5, four weeks after it had been initially scheduled, with opening evidence expected October 26. Hours later, Acting Manhattan Supreme Court Justice Gregory Carro rescheduled the state trial from June 8 to September 8.

The defense team, led by attorneys Karen Friedman Agnifilo and Marc Agnifilo, has argued that running two prosecutions on a compressed, back-to-back timeline amounts to a constitutional violation. In seeking the delays, Mangione's lawyers argued that back-to-back prosecutions on a tight timeline would violate his constitutional rights. The sequence now places the state trial in September, followed by federal jury selection in October, a calendar that the defense views as still problematic. In a court appearance in early April, Mangione himself "lashed out about double jeopardy," a rare moment of visible emotion from the typically composed defendant.

On January 30, 2026, U.S. District Judge Margaret Garnett dismissed two federal charges, including a death-eligible "murder through" count, narrowing but not eliminating the federal exposure Mangione faces. He has pleaded not guilty to all charges and faces the possibility of life in prison if convicted in either case.

Why It Matters: The Mangione case is shaping up as a landmark test of how federal and state systems coordinate, or fail to, when both want to prosecute the same defendant for the same act. The simultaneous proceedings raise a genuine constitutional question about whether sequential trials for the same underlying killing, under different sovereigns, crosses a due process line even when the formal double jeopardy doctrine technically permits it. The next critical decision points are the September 8 state trial start date and any further motions on admissibility of evidence, which could delay proceedings once again. The case also carries an outsized cultural weight: the public debate over insurance industry accountability that erupted after Thompson's killing has never fully subsided, and whatever verdict emerges will land in that charged atmosphere.